AzTrials
AzTrials

Hearing LossNCT02407587

Neuroplastic Changes Seen in Cochlear Implants With Preserved Hearing

A study testing cochlear implants in people with Hearing Loss, run by Manchester University NHS Foundation Trust at 1 site in United Kingdom.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Investigators hope to study patients with 1 cochlear implant and who have had hearing preservation surgery and compare the changes in the brain of these patients with normal hearing patients by doing a scan of the brain when listening to speech. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Hearing Loss
What is being tested?
cochlear implants
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited Kingdom
Study dates
May 2013to 27 Feb 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Mature users of unilateral cochlear implants who have natural preserved hearing in the implanted ear
  • Healthy volunteers with normal hearing
  • Right handed

Who cannot join

  • Individuals with neurological or psychiatric illness
  • Patients involved in additional drug trials
  • Pregnant or breast feeding women
  • Children
  • Left-handed subjects

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Central Manchester University Hospitals NHS Foundation Trust

    Manchester, Manchester (Manchester Borough), M13 9WL

Other trials in United Kingdom

About this study

Official title: Cortical Activity in Subjects With Unilateral Cochlear Implants and Preserved Ipsilateral Residual Hearing and the Evolution of Temporal Cortex Changes in New Recipients of Cochlear Implants.

Investigators hope to study patients with 1 cochlear implant and who have had hearing preservation surgery and compare the changes in the brain of these patients with normal hearing patients by doing a scan of the brain when listening to speech. The information investigators collect may help investigators to understand how the brain learns to hear with a cochlear implant and whether it uses the same areas in the brain to listen as in normal hearing patients as well as predict which patients will do well with a cochlear implant as a very specialised operation is needed to insert the cochlear implant in to the ear and is done by very few surgeons in the country. After the operation, patients need several months of teaching to help them learn how to hear through the implant. Having a cochlear implant requires a lot of cooperation and time from the patient and if investigators could understand how the brain learns to hear with a cochlear implant and predict which patients do well and why then we may be able to avoid unnecessary procedures.

Read the detailed description

Cochlear implants are an established treatment for individuals with hearing loss where conventional hearing aids fail to provide appropriate hearing amplification and result in poor speech and language perception.

Although a large proportion of patients with cochlear implants are expected to do well with an implant, there is still uncertainty why some individuals do poorly.

Furthermore investigators have limited knowledge about how the brain interacts with a cochlear implant to process speech. Evidence suggests that the underlying central mechanisms responsible for processing speech using an implant are related to neuroplasticity. That is to say that the brain establishes new cortical networks between the vital auditory centres and the cochlear implant thus enabling processing of speech.

Investigators have recently completed a study comparing the cortical changes that occur in subjects with bilateral cochlear implants to normal hearing controls. In this study both groups of patients were subjected to binaural simultaneous auditory stimuli. Analysis suggests that subjects with bilateral cochlear implants and postlingual hearing loss seem to recruit similar areas of the temporal lobes to process speech as their normal hearing counterparts.

The implant recipients activations were larger and more diffuse but did not differ greatly from those described previously in normal hearing. This study provides a good comparison of hearing using bilateral cochlear implants to that of normal unaided hearing. This study provides a more realistic comparison of cortical activations due to hearing in cochlear implantees and normal hearing subjects. This is in contrast to other studies involving monaural stimulation of a unilateral cochlear implant to monaural stimulation of normal hearing subject with the contralateral normal hearing ear blocked off. Investigators are only aware of one additional study where subjects with bilateral cochlear implants have been compared to normal hearing controls.

In addition investigators did not observe any recruitment of the visual cortices in our bilaterally implanted subjects. This finding was also present in Strelnikov's study. However previous work has suggested subjects with cochlear implants rely on visual clues to process speech as a result of the degraded signal provided by the implant. It is possible that because the subjects in this study and Strelnikov's study were experienced implant users and benefited from binaural auditory stimulation, they were not dependant on audio-visual integration to process speech.

There has been an increasing trend towards hearing preservation surgery for patients undergoing cochlear implantation. Literature supports improved speech and pitch perception in quiet and noise for subjects who combine the use of their implant with any residual preserved natural hearing compared with using the implant alone. Once again the the underlying mechanisms for this are unknown. It would be of scientific interest to investigate the interaction between natural residual hearing and hearing via a cochlear implant. It is likely that this cohort of subjects process speech similarly to those with normal hearing.

Finally, studies have monitored the speech progression of implantees from before surgery to several years post implant switch on. It has been suggested that the predominant improvement in speech perception occurs in the first year of implant use. This would suggest that the neuronal networks responsible for speech processing are established very early on however, investigators are not aware of any studies which have attempted to track the evolution of the temporal cortices in new recipients of cochlear implants.

Conditions
Hearing Loss
Being tested
cochlear implants
Medical subject headings
Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cochlear implantsDevice

    PET scans for the mature patients with unilateral cochlear implants and preserved hearing

    4 states and each state will be repeated 3 times Cochlear implant only Residual hearing only Combination of implant and residual hearing No auditory stimulation

Study groups in NCT02407587
Study groupRoleWhat they receive
unilateral cochlear implantsExperimentalStudy Group PET scans for the mature patients with unilateral cochlear implants and preserved hearing 4 states and each state will be repeated 3 times Cochlear implant only Residual hearing only Combination of implant and residual hearing No auditory stimulation
Receives: Device: cochlear implants
Healthy volunteersNo intervention4 states and each state will be repeated 3 times Auditory stimulation Left ear only Auditory stimulation right ear only Binaural auditory stimulation Silence

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Increase our understanding of why outcomes following a cochlear implant are heterogenous. This information may be used to provide targeted rehabilitation for candidates performing poorly with their implants and minimise rejection of the implant.

    We anticipate that the recruitment of patients, data collection and analysis would take a maximum of 4 months

    Study Group

    PET scans for the mature patients with unilateral cochlear implants and preserved hearing

    4 states and each state will be repeated 3 times Cochlear implant only Residual hearing only Combination of implant and residual hearing No auditory stimulation

    Control Group

    4 states and each state will be repeated 3 times Auditory stimulation Left ear only Auditory stimulation right ear only Binaural auditory stimulation Silence

    Measured: 1 year

Secondary outcomes (2)
  1. Combine the data from both of our studies and future studies in order to conduct meta-analysis to investigate further how language is processed in patients with cochlear implants.

    Measured: 1 year

  2. Determine if functional neuroimaging modalities have a future role in the selection process for potential cochlear implant candidates and in predicting outcome for each individual.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2015 (estimated)
  2. Study startMay 2013 (estimated)
  3. Primary completionOct 2015 (estimated)
  4. Study completion27 Feb 2017

Why it stopped: unresolved issues with a collaborator.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02407587
Sponsor's protocol ID
R01997
Status last verified
Jan 2019
First submitted
18 Sep 2014
Last updated
18 Jan 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing cochlear implants in people with Hearing Loss, run by Manchester University NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 18 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Increase our understanding of why outcomes following a cochlear implant are heterogenous. This information may be used to provide targeted rehabilitation for candidates performing poorly with their implants and minimise rejection of the implant. (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2019; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in